BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 19015385)

  • 1. Future directions in cardiovascular pharmacology: examples from the Renin-Angiotensin system.
    Diz DI
    Mol Interv; 2008 Oct; 8(5):222-5. PubMed ID: 19015385
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prospective trends in the study of the therapeutic action of angiotensin-converting enzyme inhibitors in cardiovascular diseases].
    Novikova LS; Arabidze GG
    Ter Arkh; 1990; 62(1):118-23. PubMed ID: 2159193
    [No Abstract]   [Full Text] [Related]  

  • 3. Effectively targetting the renin-angiotensin-aldosterone system in cardiovascular and renal disease: rationale for using angiotensin II receptor blockers in combination with angiotensin-converting enzyme inhibitors.
    Weinberg MS; Weinberg AJ; Zappe DH
    J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):217-33. PubMed ID: 11881029
    [No Abstract]   [Full Text] [Related]  

  • 4. [Up-date in the renin-angiotensin system. 1) Peculiarities in children].
    Goţia S
    Rev Med Chir Soc Med Nat Iasi; 1981; 85(4):565-9. PubMed ID: 25528797
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cardiovascular pharmacology (IX). Angiotensin-converting enzyme inhibitors in hypertension and heart failure].
    de Teresa E; Espinosa JS; Gómez Doblas JJ
    Rev Esp Cardiol; 1995 Feb; 48(2):128-41. PubMed ID: 7886264
    [No Abstract]   [Full Text] [Related]  

  • 6. Circulating versus local renin-angiotensin system in cardiovascular homeostasis.
    Dzau VJ
    Circulation; 1988 Jun; 77(6 Pt 2):I4-13. PubMed ID: 3286045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of disease: local renin-angiotensin-aldosterone systems and the pathogenesis and treatment of cardiovascular disease.
    Re RN
    Nat Clin Pract Cardiovasc Med; 2004 Nov; 1(1):42-7. PubMed ID: 16265259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic potential of renin inhibitors in the management of cardiovascular disorders.
    Stanton A
    Am J Cardiovasc Drugs; 2003; 3(6):389-94. PubMed ID: 14728059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The renin-angiotensin system--from Tigerstedt to Goldblatt to ACE inhibition and beyond.
    Atlas SA; Rosendorff C
    Mt Sinai J Med; 1998 Mar; 65(2):81-6. PubMed ID: 9520510
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of the renin-angiotensin system in cardiovascular disease.
    Cohn JN
    Cardiovasc Drugs Ther; 2010 Aug; 24(4):341-4. PubMed ID: 20454841
    [No Abstract]   [Full Text] [Related]  

  • 11. Angiotensin receptor blockers and cardiovascular protection: are we ONTARGET?
    Ram CV; Deedwania PC
    Am J Cardiol; 2008 Nov; 102(9):1281-3. PubMed ID: 18940307
    [No Abstract]   [Full Text] [Related]  

  • 12. [The suppression of the renin-angiotensin system during the treatment of cardiovascular diseases].
    Eliseev OM
    Ter Arkh; 1994; 66(8):80-3. PubMed ID: 7985166
    [No Abstract]   [Full Text] [Related]  

  • 13. Blockers of the renin-angiotensin-aldosterone system: almost, but not yet, an absolute weapon against cardiovascular and renal diseases!
    Waeber B
    J Renin Angiotensin Aldosterone Syst; 2012 Mar; 13(1):216. PubMed ID: 22389390
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of renin and the (pro)renin receptor system.
    Guang C; Jiang B; Phillips RD; Milani F
    Blood Press; 2012 Dec; 21(6):377-85. PubMed ID: 22775989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The renin-angiotensin system in hypertension and heart insufficiency: current aspects in the use of ACE inhibitors].
    Greminger P; Vetter W
    Schweiz Rundsch Med Prax; 1988 Jun; 77(24):673-9. PubMed ID: 3041532
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of the renin-angiotensin-aldosterone system in cardiovascular progenitor cell function.
    Qian C; Schoemaker RG; van Gilst WH; Roks AJ
    Clin Sci (Lond); 2009 Feb; 116(4):301-14. PubMed ID: 19138171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moving beyond angiotensin II to also target aldosterone?
    Little WC; Kirkman PM
    J Am Coll Cardiol; 2009 Aug; 54(6):513-4. PubMed ID: 19643311
    [No Abstract]   [Full Text] [Related]  

  • 18. Angiotensin receptor blockers: current status and future prospects.
    Kumar S; Ram CV
    Indian Heart J; 2007; 59(6):443-53. PubMed ID: 19151457
    [No Abstract]   [Full Text] [Related]  

  • 19. [Angiotensin-converting enzyme inhibitors and ischemic heart disease].
    Ertl G; Kochsiek K
    Dtsch Med Wochenschr; 1989 Apr; 114(14):556-60. PubMed ID: 2649347
    [No Abstract]   [Full Text] [Related]  

  • 20. [The renin-angiotensin system].
    Hilgers KF
    Urologe A; 2009 Aug; 48(8):925-33; quiz 934-5. PubMed ID: 19669119
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.